Approximately 60 per cent of nerve damage in Diabetes patients is never diagnosed. LARA Diagnostics has a technique for helping this group, developed with help from Flemingsberg Science.
Someone who suffers from nerve damage caused by Diabetes can walk around with a stone in his or her shoe without feeling it. The stone creates a lesion on the foot which is extremely difficult to heal and can lead to parts of the foot being removed.
“This is why it’s so important that nerve damage is detected early in these patients. We are able to evaluate how well nerves work, and provide a measure of a patient’s nerve status in real time,” says Rui Chen, a civil engineer who established LARA Diagnostics with Dr. Louise Warme.
Today there are some 300,000 people with Type2 Diabetes in Sweden alone. Around half of this group suffers from peripheral nerve damage.
A speedy process
The idea for LARA Diagnostics came about under the auspices of CTMH Clinical Innovation Fellowships, a programme driven by the goal of developing clinical innovations. Product development has been conducted in close co-operation with caregivers.
“The prototypes have been rigorously tested and this has resulted in our rapid success. The finished product could be available within an year or so,” says Chen.
To date, the project has been supported financially by Vinnova and Almi, and has also received the SKAPA foundation’s development endowment.
“Flemingsberg Science has provided valuable advice and coaching throughout our development, as well as functioning as a link to financing for patent applications. Furthermore, KTH Innovation and CTMH have been invaluable,” adds Chen.